deltatrials
Recruiting PHASE3 INTERVENTIONAL 2-arm NCT06626022

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. (MUSIC-Screen)

A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen)

Sponsor: University of Alberta

Interventions ExactVu MRI
Updated 5 times since 2024 Last updated: Mar 11, 2026 Started: May 8, 2025 Primary completion: Nov 30, 2029 Completion: Nov 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Prostate Cancer Screening and is currently actively recruiting participants. University of Alberta leads this study, which shows 5 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Nov 2024 – ~Feb 2025 · 3 months · monthly snapshotNot Yet Recruiting~Feb 2025 – ~Apr 2025 · 59 days · monthly snapshotNot Yet Recruiting~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshotNot Yet Recruiting~Jun 2025 – ~Mar 2026 · 9 months · monthly snapshotRecruiting~Mar 2026 – present · 4 months · monthly snapshotRecruiting

Change History

5 versions recorded
  1. Mar 2026 — Present [monthly]

    Recruiting PHASE3

  2. Jun 2025 — Mar 2026 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  3. Apr 2025 — Jun 2025 [monthly]

    Not Yet Recruiting PHASE3

  4. Feb 2025 — Apr 2025 [monthly]

    Not Yet Recruiting PHASE3

  5. Nov 2024 — Feb 2025 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Alberta
Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .